Prostate Cancer

Trial Immune gene expression and tumour microenvironment in prostate cancer
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Belfast City Hospital
Information

How does radiotherapy affect immune gene expression and the tumour microenvironment in men with localised prostate cancer?

Trial Lantern Pharma
Cancer Type Prostate Cancer
Hospital(s) Altnagelvin Hospital
Information

Biomarker analysis using fresh biopsy tissue

Trial PACE-NODES
Cancer Type Prostate Cancer
Hospital(s) Belfast City Hospital
Information

A phase III randomised trial of 5 fraction prostate SBRT versus 5 fraction prostate and pelvic nodal SBRT

Trial Pivotal Boost
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Belfast City Hospital
Information

A Phase III Randomised Controlled Trial of Prostate and Pelvis Versus Prostate Alone Radiotherapy With Or Without Prostate Boost

Trial PSMAddition
Cancer Type Prostate Cancer
Hospital(s) Belfast City Hospital
Information

An International Prospective Open-Label, Randomised, Phase 3 Study Comparing 177Lu-PSMA-617 In Combination With Standard of Care, Versus Standard Of Care Alone, In Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer

Trial SABRE
Cancer Type Prostate Cancer
Hospital(s) Belfast City Hospital
Information

Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body RadiothErapy

Trial UKGPC
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Altnagelvin Hospital, Antrim Hospital, and Ulster Hospital
Information

UK Genetics Prostate Cancer Study

Click Here to view CancerHelpUK trial summary